119 related articles for article (PubMed ID: 38565071)
21. Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.
Bhatia H; Pattnaik BR; Datta M
Int J Obes (Lond); 2016 May; 40(5):861-9. PubMed ID: 26499439
[TBL] [Abstract][Full Text] [Related]
22. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
23. miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3.
Xu L; Li Y; Yin L; Qi Y; Sun H; Sun P; Xu M; Tang Z; Peng J
Theranostics; 2018; 8(20):5593-5609. PubMed ID: 30555566
[TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance.
Sud N; Zhang H; Pan K; Cheng X; Cui J; Su Q
J Nutr Biochem; 2017 May; 43():125-131. PubMed ID: 28284064
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.
Ng R; Wu H; Xiao H; Chen X; Willenbring H; Steer CJ; Song G
Hepatology; 2014 Aug; 60(2):554-64. PubMed ID: 24677249
[TBL] [Abstract][Full Text] [Related]
26. Branched-chain keto acids inhibit mitochondrial pyruvate carrier and suppress gluconeogenesis in hepatocytes.
Nishi K; Yoshii A; Abell L; Zhou B; Frausto R; Ritterhoff J; McMillen TS; Sweet I; Wang Y; Gao C; Tian R
Cell Rep; 2023 Jun; 42(6):112641. PubMed ID: 37310861
[TBL] [Abstract][Full Text] [Related]
27. miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder.
Fan L; Lai R; Ma N; Dong Y; Li Y; Wu Q; Qiao J; Lu H; Gong L; Tao Z; Chen J; Xie Q; Ren J
J Hepatol; 2021 Jan; 74(1):8-19. PubMed ID: 32818571
[TBL] [Abstract][Full Text] [Related]
28. MiR-125a-3p-KLF15-BCAA Regulates the Skeletal Muscle Branched-Chain Amino Acid Metabolism in Nile Tilapia (
Li H; An X; Bao L; Li Y; Pan Y; He J; Liu L; Zhu X; Zhang J; Cheng J; Chu W
Front Genet; 2020; 11():852. PubMed ID: 32849831
[TBL] [Abstract][Full Text] [Related]
29. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
30. Branched-Chain Amino Acids Exacerbate Obesity-Related Hepatic Glucose and Lipid Metabolic Disorders via Attenuating Akt2 Signaling.
Zhao H; Zhang F; Sun D; Wang X; Zhang X; Zhang J; Yan F; Huang C; Xie H; Lin C; Liu Y; Fan M; Yan W; Chen Y; Lian K; Li Y; Zhang L; Wang S; Tao L
Diabetes; 2020 Jun; 69(6):1164-1177. PubMed ID: 32184272
[TBL] [Abstract][Full Text] [Related]
31. miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1.
Guo Y; Yu J; Wang C; Li K; Liu B; Du Y; Xiao F; Chen S; Guo F
J Mol Endocrinol; 2017 Oct; 59(3):205-217. PubMed ID: 28667176
[TBL] [Abstract][Full Text] [Related]
32. Rhythmic expression of miR-27b-3p targets the clock gene Bmal1 at the posttranscriptional level in the mouse liver.
Zhang W; Wang P; Chen S; Zhang Z; Liang T; Liu C
FASEB J; 2016 Jun; 30(6):2151-60. PubMed ID: 26919869
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic inhibition of miR-802 protects against obesity through AMPK-mediated regulation of hepatic lipid metabolism.
Ni Y; Xu Z; Li C; Zhu Y; Liu R; Zhang F; Chang H; Li M; Sheng L; Li Z; Hou M; Chen L; You H; McManus DP; Hu W; Duan Y; Liu Y; Ji M
Theranostics; 2021; 11(3):1079-1099. PubMed ID: 33391522
[No Abstract] [Full Text] [Related]
34. Impaired adiponectin signaling contributes to disturbed catabolism of branched-chain amino acids in diabetic mice.
Lian K; Du C; Liu Y; Zhu D; Yan W; Zhang H; Hong Z; Liu P; Zhang L; Pei H; Zhang J; Gao C; Xin C; Cheng H; Xiong L; Tao L
Diabetes; 2015 Jan; 64(1):49-59. PubMed ID: 25071024
[TBL] [Abstract][Full Text] [Related]
35. A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver.
Mattis AN; Song G; Hitchner K; Kim RY; Lee AY; Sharma AD; Malato Y; McManus MT; Esau CC; Koller E; Koliwad S; Lim LP; Maher JJ; Raffai RL; Willenbring H
Hepatology; 2015 Jan; 61(1):141-52. PubMed ID: 25131933
[TBL] [Abstract][Full Text] [Related]
36. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
37. MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1.
Ding J; Xia C; Cen P; Li S; Yu L; Zhu J; Jin J
Mol Biol Rep; 2022 Aug; 49(8):7297-7305. PubMed ID: 35606603
[TBL] [Abstract][Full Text] [Related]
38. miR-130b duplex (miR-130b-3p/miR-130b-5p) negatively regulates goat intramuscular preadipocyte lipid droplets accumulation by inhibiting Krüppel-like factor 3 expression.
Li Y; He C; Ran L; Wang Y; Xiong Y; Wang Y; Zhu J; Lin Y
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37279650
[TBL] [Abstract][Full Text] [Related]
39. miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
Wang YD; Wu LL; Mai YN; Wang K; Tang Y; Wang QY; Li JY; Jiang LY; Liao ZZ; Hu C; Wang YY; Liu JJ; Liu JH; Xiao XH
Metabolism; 2023 Sep; 146():155660. PubMed ID: 37451670
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes.
Chen L; Wu N; Kennedy L; Francis H; Ceci L; Zhou T; Samala N; Kyritsi K; Wu C; Sybenga A; Ekser B; Dar W; Atkins C; Meadows V; Glaser S; Alpini G
Hepatology; 2021 Oct; 74(4):1845-1863. PubMed ID: 33928675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
